BENZALKONIUM

BENZALKONIUM was reported 439 times

BENZALKONIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DERMABRASION 1 0.0238
1 GASTROINTESTINAL TOXICITY 20 0.0042
2 OCULAR SURFACE DISEASE 1 0.0036
3 MORGANELLA INFECTION 1 0.0034
4 INCORRECT PRODUCT FORMULATION ADMINISTERED 3 0.0034
5 C-REACTIVE PROTEIN ABNORMAL 20 0.0031
6 RHYTHM IDIOVENTRICULAR 1 0.0031
7 NEPHROSTOMY 1 0.0030
8 PULMONARY TOXICITY 20 0.0028
9 ABSCESS BACTERIAL 1 0.0028
10 TOXIC ANTERIOR SEGMENT SYNDROME 3 0.0027
11 LEUKOCYTURIA 1 0.0012
12 JOINT INJURY 20 0.0009
13 HEPATOTOXICITY 20 0.0009
14 JOINT STIFFNESS 20 0.0008
15 ACROCHORDON 1 0.0008
16 CULTURE URINE POSITIVE 1 0.0007
17 NODAL RHYTHM 1 0.0007
18 HEAT STROKE 1 0.0007
19 SINUS ARREST 1 0.0006
20 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
21 CATHETER SITE ERYTHEMA 1 0.0005
22 THERAPY NON-RESPONDER 20 0.0004
23 FLAT AFFECT 1 0.0004
24 MUSCULOSKELETAL PAIN 21 0.0004
25 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
26 NEOPLASM MALIGNANT 20 0.0003
27 WOUND COMPLICATION 1 0.0003
28 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
29 TREATMENT FAILURE 20 0.0002
30 MUSCULOSKELETAL STIFFNESS 20 0.0002
31 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
32 ARTHROPATHY 12 0.0002
33 KLEBSIELLA INFECTION 1 0.0002
34 INFLAMMATION 10 0.0002
35 PRODUCT LEAKAGE 1 0.0002
36 SKIN WARM 1 0.0002
37 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
38 JOINT SWELLING 20 0.0002
39 APHASIA 5 0.0002
40 ONYCHOCLASIS 1 0.0001
41 INFECTION 21 0.0001
42 RHEUMATOID ARTHRITIS 16 0.0001
43 RASH PUSTULAR 1 0.0001
44 SENSITIVE SKIN 1 0.0001
45 DRUG INTOLERANCE 12 0.0001
46 PETECHIAE 1 0.0001
47 SKIN INFECTION 1 0.0001
48 IMPAIRED DRIVING ABILITY 1 0.0001
49 DERMATITIS CONTACT 1 0.0001
50 COVID-19 PNEUMONIA 1 0.0001
51 NOCTURIA 1 0.0001
52 PAIN IN EXTREMITY 21 0.0001
53 DEVICE RELATED INFECTION 1 0.0001
54 PERIPHERAL SWELLING 10 0.0001
55 OBESITY 1 0.0001
56 CONDITION AGGRAVATED 19 0.0001
57 STAPHYLOCOCCAL INFECTION 2 0.0001
58 DRUG ERUPTION 1 0.0001
59 GLAUCOMA 1 0.0001
60 ARTHRALGIA 21 0.0001
61 UNRESPONSIVE TO STIMULI 1 0.0000
62 SKIN ULCER 1 0.0000
63 EXPOSURE VIA SKIN CONTACT 1 0.0000
64 FREQUENT BOWEL MOVEMENTS 1 0.0000
65 PALLOR 1 0.0000
66 SKIN LESION 1 0.0000
67 INJECTION SITE RASH 1 0.0000
68 DEVICE USE ERROR 1 0.0000
69 RASH MACULAR 1 0.0000
70 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
71 SEPSIS 3 0.0000
72 SKIN IRRITATION 1 0.0000
73 RASH ERYTHEMATOUS 1 0.0000
74 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
75 ECZEMA 1 0.0000
76 BRADYCARDIA 1 0.0000
77 RASH PRURITIC 1 0.0000
78 BLISTER 1 0.0000
79 EYE PAIN 1 0.0000
80 FLATULENCE 1 0.0000
81 DRUG INEFFECTIVE 21 0.0000
82 FEBRILE NEUTROPENIA 1 0.0000
83 INJECTION SITE PRURITUS 1 0.0000
84 BURNING SENSATION 1 0.0000
85 SKIN EXFOLIATION 1 0.0000
86 BALANCE DISORDER 1 0.0000
87 RASH 5 0.0000
88 DEVICE ISSUE 1 0.0000
89 HYPERSENSITIVITY 2 0.0000
90 SYNCOPE 1 0.0000
91 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
92 MUSCULAR WEAKNESS 1 0.0000
93 OEDEMA PERIPHERAL 1 0.0000
94 INJECTION SITE ERYTHEMA 1 0.0000
95 OFF LABEL USE 7 0.0000
96 DRY SKIN 1 0.0000
97 VISION BLURRED 1 0.0000
98 PNEUMONIA 2 0.0000
99 CHEST PAIN 1 0.0000
100 BLOOD GLUCOSE INCREASED 1 0.0000
101 ERYTHEMA 1 0.0000
102 DEPRESSION 1 0.0000
103 ABDOMINAL PAIN 1 0.0000
104 DYSPNOEA 2 0.0000
105 PRODUCT DOSE OMISSION ISSUE 1 0.0000
106 INJECTION SITE PAIN 1 0.0000
107 PYREXIA 1 0.0000
108 ASTHENIA 1 0.0000
109 PAIN 1 0.0000
110 FATIGUE 1 0.0000
111 DEATH 1 0.0000